ArticleMediators of inflammation2026
Investigating the Relationships Among Gut Microbiota, Inflammatory Cytokines, Cerebrovascular Diseases, and the Mediation Pathways.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Investigating the Relationships Among Gut Microbiota, Inflammatory Cytokines, Cerebrovascular Diseases, and the Mediation Pathways.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Cerebrovascular disease (CeVD), the second leading global cause of death, has an incompletely understood pathogenesis. This study aimed to investigate causal relationships among gut microbiota, inflammatory cytokines, and CeVD, specifically examining inflammatory cytokine-mediated pathways. Methods: Genome-wide association study (GWAS) summary statistics for 209 gut microbial taxa, 91 inflammatory cytokines, and three CeVD subtypes were obtained from publicly available datasets. Causal effects were estimated by applying four complementary two-sample Mendelian randomization (MR) methods. Reverse MR and comprehensive sensitivity analyses were performed to validate the robustness of the findings. Multivariable MR (MVMR) analyses were conducted to account for potential confounders. Mediation analysis was conducted to elucidate the pathways from gut microbiota to CeVD, mediated by inflammatory cytokines. Results: Our study identified 33 gut microbiota significantly associated with CeVD, including nine with ischemic stroke (IS), 14 with intracerebral hemorrhage (ICH), and 10 with subarachnoid hemorrhage (SAH). Eighteen inflammatory cytokines showed significant associations with different CeVD subtypes. Mediation analysis revealed 10 causal pathways from gut microbiota to CeVD mediated by inflammatory cytokines; among these, three inflammatory cytokines mediated more than two pathways. Conclusions: This study demonstrated that inflammatory cytokines mediated the gut microbiota-CeVD causal pathway through genetic evidence, elucidating novel disease mechanisms, thereby providing actionable insights for developing CeVD prevention and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.